Orion Corporation: Transfer of 150,118 own B shares on 1 March 2024

Udgivet den 01-03-2024  |  kl. 16:50  |  

ORION CORPORATION
STOCK EXCHANGE RELEASE - CHANGES IN COMPANY'S OWN SHARES
1 MARCH 2024 at 18.50 EET

        
Orion Corporation: Transfer of 150,118 own B shares on 1 March 2024

In accordance with a decision by the Board of Directors, Orion Corporation has on 1 March 2024 transferred altogether 150,118 Orion Corporation B shares held by the company as a share reward for earning period 2021-2023 to the persons belonging to the Share-based Incentive Plan of the Orion Group. The transfer is based on the authorisation by the Annual General Meeting of 23 March 2022.

The price per share of the transferred shares is EUR 36.4279, which is the volume weighted average quotation of the Orion Corporation B share on 1 March 2024. Accordingly, the total transaction price of the transferred shares is EUR 5,468,483.49.

After the share transfer, the total number of own B shares held by Orion Corporation is 632,855.

Orion Corporation has informed about the Share-based Incentive Plan in stock exchange release on 6 February 2019.

Orion Corporation

Liisa Hurme
President and CEO		     Olli Huotari
SVP, Corporate Functions		  

                                                
Contact person:
Olli Huotari, SVP, Corporate Functions
tel. +358 10 426 3054

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR

Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2023 amounted to EUR 1,190 million and the company had about 3,600 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.


\Hugin

Udgivet af: NPinvestordk

Mest læste lige nu

Novo får skåret kursmål af Argus
DSV's anbefaling hæves til "outperform" og kursmålet løftes 50 pct. hos BNP Paribas
DFDS-aktien i vejret efter alligevel at være kommet i mål med tyrkisk opkøb
Novonesis får ændret kursmål med 25 kr. af Barclays og SEB
Fredagens aktier: Nedtur til medicinalaktierne trak C25 i laveste niveau i år
 

Seneste nyheder

07:43 Råvarer: Udsigt til større produktion og svag efterspørgsel sænker oliepriserne
07:38 Vestas får sænket anbefalingen til "hold" af tysk finanshus
07:22 Obligationer/tendens: Små renteløft i sigte efter sene amerikanske plusser
07:09 Lundbeck får løftet kursmålet hos Nordea efter regnskab
06:41 Novo får skåret kursmål af Argus
06:40 Asien: Uvished præger aktiehandlen efter amerikanske inflationsdata
06:35 Svitzers kursmål skåret med 20 kr. hos HSBC
06:34 Torm får skåret kursmål til 226,48 kr. af Jefferies
06:32 Asien: Uvished præger aktiehandlen efter amerikanske inflationsdata
06:32 Valuta: Dollar på stærkeste niveau i halvandet år
06:32 USA/T-bond: Korte renter satte sig efter inflationstal - stigning i den lange ende
06:32 USA/lukning: Marginal fremgang onsdag - Amazon i rekord
06:30 Kalender med link - torsdag den 14. november
17:58 Gubra melder om positive resultater fra fase 1-studie med fedmebehandling
17:47 Europa/aktier: Siemens Energy, RWE og Just Eat trak tungt Stoxx 600 mod nul
17:05 Onsdagens aktier: Lundbeck festede mens C25 igen var præget af begravelsesstemning
17:00 Onsdagens obligationer: Mindre rentestigning efter amerikansk inflationsrapport
16:11 Freetrailer indgår ny strategisk forsikringsaftale med Tryg
15:38 USA/åbning: Igen grønt på menuen efter inflationsrapport uden negative overraskelser
15:12 Tørlastindekset Baltic Dry falder marginalt efter seks dage med stigninger